extrapyramidal side effects of serotonin reuptake inhibitors.
Neuropsychopharmacology, in press.
Brezun JM, Daszuta A (1999) Depletion in serotonin decreases neurogenesis in the dentate gyrus and the subventricular zone of adult
rats. Neuroscience 89:999 –1002.
Cain ME, Saucier DA, Bardo MT (2005) Novelty seeking and drug use:
contribution of an animal model. Exp Clin Psychopharmacol
13:367–375.
Chaillan FA, Truchet B, Roman FS, Soumireu-Mourat B (1999) Early
polysynaptic potentiation recorded in the dentate gyrus during an
associative learning task. Neuroscience 94:443– 451.
Cools AR, Ellenbroek B, Heeren D, Lubbers L (1993) Use of high and
low responders to novelty in rat studies on the role of the ventral
striatum in radial maze performance: effects of intra-accumbens
injections of sulpiride. Can J Physiol Pharmacol 71:335–342.
Costall B, Naylor RJ (2004) 5-HT3 receptors. Curr Drug Targets CNS
Neurol Disord 3:27–37.
Dawson LA, Nguyen HQ, Li P (2003) Potentiation of amphetamineinduced changes in dopamine and 5-HT by a 5-HT(6) receptor
antagonist. Brain Res Bull 59:513–521.
Dellu F, Piazza PV, Mayo W, Le Moal M, Simon H (1996) Noveltyseeking in rats-biobehavioral characteristics and possible relationship with the sensation-seeking trait in man. Neuropsychobiology
34:136 –145.
Eglen RM, Jasper JR, Chang DJ, Martin GR (1997) The 5-HT7
receptor: orphan found. Trends Pharmacol Sci 18:104 –107.
Faerber L, Drechsler S, Ladenburger S, Gschaidmeier H, Fischer W
(2007) The neuronal 5-HT(3) receptor network after 20 years of
research: Evolving concepts in management of pain and inflammation. Eur J Pharmacol 560:1– 8.
Filip M, Nowak E, Papla I (2001) On the role of serotonin2A/2C
receptors in the sensitization to cocaine. J Physiol Pharmacol
52:471– 481.
Frantz KJ, Hansson KJ, Stouffer DG, Parsons LH (2002) 5-HT(6)
receptor antagonism potentiates the behavioral and neurochemical effects of amphetamine but not cocaine. Neuropharmacology
42:170 –180.
Gerard C, Martres MP, Lefevre K, Miquel MC, Verge D, Lanfumey L,
Doucet E, Hamon M, el Mestikawy S (1997) Immuno-localization of
serotonin 5-HT6 receptor-like material in the rat central nervous
system. Brain Res 746:207–219.
Goaillard JM, Vincent P (2002) Serotonin suppresses the slow afterhyperpolarization in rat intralaminar and midline thalamic neurones
by activating 5-HT(7) receptors. J Physiol 541:453– 465.
Guscott M, Bristow LJ, Hadingham K, Rosahl TW, Beer MS, Stanton
JA, Bromidge F, Owens AP, Huscroft I, Myers J, Rupniak NM,
Patel S, Whiting PJ, Hutson PH, Fone KC, Biello SM, Kulagowski
JJ, McAllister G (2005) Genetic knockout and pharmacological
blockade studies of the 5-HT7 receptor suggest therapeutic potential in depression. Neuropharmacology 48:492–502.
Gustafson EL, Durkin MM, Bard JA, Zgombick J, Branchek TA (1996)
A receptor autoradiographic and in situ hybridization analysis of the
distribution of the 5-HT7 receptor in rat brain. Br J Pharmacol
117:657– 666.
Hamon M, Doucet E, Lefevre K, Miquel MC, Lanfumey L, Insausti R,
Frechilla D, Del Rio J, Verge D (1999) Antibodies and antisense
oligonucleotide for probing the distribution and putative functions of
central 5-HT6 receptors. Neuropsychopharmacology 21:68S–76S.
Hedlund PB, Huitron-Resendiz S, Henriksen SJ, Sutcliffe JG (2005)
5-HT7 receptor inhibition and inactivation induce antidepressantlike behavior and sleep pattern. Biol Psychiatry 58:831– 837.
Hedlund PB, Sutcliffe JG (2004) Functional, molecular and pharmacological advances in 5-HT7 receptor research. Trends Pharmacol
Sci 25:481– 486.
Herve D, Simon H, Blanc G, Lemoal M, Glowinski J, Tassin JP (1981)
Opposite changes in dopamine utilization in the nucleus accumbens and the frontal cortex after electrolytic lesion of the median
raphe in the rat. Brain Res 216:422– 428.
